The FDA announced yesterday that is has approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in ...
Sales of its asthma and COPD medication Advair are declining, and payers are demanding more from its next generation treatments Breo and Anoro Ellipta. “Digital innovations, like sensor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback